BICO Group Overview
- Status
-
Public
- Employees
-
554
- Stock Symbol
-
BICO
- Investments
-
16
- Share Price
-
$1.56
- (As of Thursday Closing)
BICO Group General Information
Description
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
Contact Information
Website
www.bico.comCorporate Office
- Grafiska vägen 2B
- 412 63 Gothenburg
- Sweden
Corporate Office
- Grafiska vägen 2B
- 412 63 Gothenburg
- Sweden
BICO Group Timeline
BICO Group Stock Performance
As of 19-Nov-2026, BICO Group’s stock price is $1.56. Its current market cap is $110M with 70.6M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.56 | $1.61 | $1.33 - $2.58 | $110M | 70.6M | 406K | -$0.68 |
BICO Group Financials Summary
As of 30-Sep-2026, BICO Group has a trailing 12-month revenue of $168M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 160,178 | 168,074 | 320,617 | 536,610 |
| Revenue | 168,416 | 152,391 | 163,314 | 189,141 |
| EBITDA | 12,473 | (132,981) | 26,693 | 14,837 |
| Net Income | (47,699) | (110,833) | (520) | (110,329) |
| Total Assets | 257,859 | 401,721 | 496,959 | 606,347 |
| Total Debt | 69,757 | 139,840 | 159,822 | 195,939 |
BICO Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
BICO Group Patents
BICO Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220349007-A1 | Method of culturing and analyzing at least one cell in a microchamber configured to allow for optical inspection of the at least one cell, a device for use in the method, a system and a computer program for performing one or more of the steps of the method | Inactive | 29-Apr-2021 | ||
| US-20240157629-A1 | 3d bioprinter with continuous workflow capability | Inactive | 12-Mar-2021 | ||
| WO-2022180565-A1 | Silk fibroin and related use for 3d bioprinting | Inactive | 25-Feb-2021 | ||
| US-20240131220-A1 | Silk fibroin bioinks and related use for 3d bioprinting | Pending | 25-Feb-2021 | ||
| US-20240226377-A9 | Silk fibroin bioinks and related use for 3d bioprinting | Pending | 25-Feb-2021 | A61L27/26 |
BICO Group Signals
BICO Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
BICO Group Investments & Acquisitions (16)
BICO Group’s most recent deal was a Merger/Acquisition with Allegro 3D for . The deal was made on 05-May-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Allegro 3D | 05-May-2022 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| Biosero | 16-Dec-2021 | Merger/Acquisition | Business/Productivity Software | ||
| QInstruments | 15-Oct-2021 | Merger/Acquisition | Other Devices and Supplies | ||
| Nanochon | 01-Oct-2021 | Seed Round | Therapeutic Devices | ||
| Hurel | 15-Sep-2021 | Merger/Acquisition | Discovery Tools (Healthcare) |
BICO Group ESG
Risk Overview
Risk Rating
Updated November, 30, 2024
18.59 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 14,271
Rank
Percentile
Pharmaceuticals
Industry
of 908
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 68
Rank
Percentile
BICO Group Exits (4)
BICO Group’s most recent exit was on 20-May-2021 from Visikol. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Visikol | 20-May-2021 | Completed |
|
||
| MatTek | 22-Mar-2021 | Completed |
|
||
| Ginolis | 01-Mar-2021 | Completed |
|
||
| Cytena Bioprocess Solutions | 29-Dec-2020 | Early Stage VC | Completed |
|
BICO Group Affiliates
Subsidiaries (9)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Bico International | Goteborg, Sweden | 2018 | |
| Dispendix | Stuttgart, Germany | 2016 | |
| Cytena | Freiburg, Germany | 2014 | |
| Discover Echo | San Diego, CA | 2013 | |
| Ginolis | Oulu, Finland | 2010 |
BICO Group FAQs
-
Where is BICO Group headquartered?
BICO Group is headquartered in Gothenburg, Sweden.
-
What is the size of BICO Group?
BICO Group has 554 total employees.
-
What industry is BICO Group in?
BICO Group’s primary industry is Biotechnology.
-
Is BICO Group a private or public company?
BICO Group is a Public company.
-
What is BICO Group’s stock symbol?
The ticker symbol for BICO Group is BICO.
-
What is the current stock price of BICO Group?
As of 19-Nov-2026 the stock price of BICO Group is $1.56.
-
What is the current market cap of BICO Group?
The current market capitalization of BICO Group is $110M.
-
What is BICO Group’s current revenue?
The trailing twelve month revenue for BICO Group is $168M.
-
What is BICO Group’s annual earnings per share (EPS)?
BICO Group’s EPS for 12 months was -$0.68.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process